4.5 Letter

Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen

Journal

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 65, Issue 5, Pages 793-794

Publisher

WILEY
DOI: 10.1111/j.1365-2125.2008.03119.x

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available